Akari Therapeutics PLC
F:CLA
Akari Therapeutics PLC
F:CLA
Price:
0.0556
EUR
Market Closed
Market Cap:
€198.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Akari Therapeutics PLC
F:CLA
|
US |
|
Re/Max Holdings Inc
NYSE:RMAX
|
US |
|
A
|
Ananda Development PCL
SET:ANAN
|
TH |
|
A
|
Abeona Therapeutics Inc
F:PCJP
|
US |
|
P
|
PDS Biotechnology Corp
F:EU6
|
US |
|
F
|
Fennec Pharmaceuticals Inc
TSX:FRX
|
US |
|
Cbrain A/S
F:C6F
|
DK |
|
Avalo Therapeutics Inc
F:C6K
|
US |
|
N
|
North American Construction Group Ltd
XBER:N5Z
|
CA |
|
M
|
Marathon Petroleum Corp
XBER:MPN
|
US |
|
U
|
United Utilities Group PLC
DUS:UUEC
|
UK |
|
E
|
Evolus Inc
F:EVL
|
US |
|
Lineage Inc
NASDAQ:LINE
|
US |
|
T
|
Toll Brothers Inc
F:TLK
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of CLA.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CLA
Multiples-Based Value
Not Available
